EFFICACY OF PIRIBEDIL AT DIFFERENT STAGES OF PARKINSON’S DISEASE
Issue:
3
Year:
2016
Piribedil reduces the degree of major motor symptoms, including the manifestations of motor fluctuations and drug-induced dyskinesia, as well as postural disorders, in Parkinson’s disease.
Keywords:
neurology
Parkinson’s disease
dopamine receptor agonists
levodopa
motor fluctuations
drug-induced dyskinesia
References:
- Diagnostika i lechenie ekstrapiramidnyh rasstrojstv. Pod red. V.N.. Shtoka / M., 2000; s. 138.
- Levin O.S., Fedorova N.V. Bolezn' Parkinsona. 3-e izd. / M.: MEDpress . inform, 2012; 352 s.
- Kadykov A.S., Manvelov L.S. Testy i shkaly v nevrologii: rukovodstvo dlja vrachej / M.: MEDpress-inform, 2015; 224 s.
- Fedorova N.V., Chigir' I.P. Bolezn' Parkinsona // Lechaschij vrach. – 2005; 6: 34–40.
- Shtok V.N., Fedorova N.V. Lechenie parkinsonizma / M., 1997; 194 s.
- Cohen G. Oxygen radicals and Parkinson's disease. Oxygen radicals and tissue injury. Ed. B. Halliwell / Federation of American Societies for Experimental Biology: Bethesda, MD, 1988; 130–5.
- Lang A. Are the new dopamine agonists better than the old ones? 67. th International congress of Parkinson's disease and movement disorders Barcelona. Spain, 2000.
- Olanow C., Obeso J. Pulsatile stimulation of dopamine receptors and 8. levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors // Neurology. – 2000; 55 (4): 72–7.
- Parkers J., Baxter R., Marsden C. et al. Comparative trial benzhexol, 9. amantadine, and levodopa in the treatment of Parkinson's disease // J. Neural. Neurosurg. Psychiatry. – 1974; 37: 422–6.